We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Experts Recommend Personalized Approach to Breast Cancer Screening

By HospiMedica International staff writers
Posted on 03 Jan 2017
Experts in the US have recommended a risk-based personalized approach to breast cancer screening to ensure improved, safer and less expensive cancer care.

Current 5-year breast cancer survival rates have reached 90% as a result of both improved treatment and screening, but this could still be improved further by taking into account the differences between women with dense breasts, those with a personal history of breast cancer, and carriers of the BRCA1 and BRCA2 gene mutations for example.

The recommendations presented by the experts from the George Washington University (Washington DC, USA) and the Memorial Sloan Kettering Cancer Center (New York, NY, USA) include annual screening using both mammography and ultrasound modalities for women aged 40 and older who have a lifetime risk of breast cancer. More...
In addition, since mammography screening alone is unable to find a third of all cancers in women with dense breast tissue, they could benefit from the addition of ultrasound screening, as revealed in a recent study of 15,000 women.

Mammography screening is not suitable for women under 40 years of age who carry the BRCA1 mutation. As an alternative, annual or biannual Magnetic Resonance Imaging (MRI) scans could increase cancer detection and reduce radiation exposure for BRCA1 carriers aged 25 to 40. For BRA1 carriers older than 40, alternating MRI and mammography screening every six months could be suitable. Contrast-Enhanced Digital Mammography (CEDM) is another possible alternative for routine mammography screening.

Related Links:
George Washington University
Memorial Sloan Kettering Cancer Center

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Fetal Monitor
BT-380
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.